Results 101 to 110 of about 616,871 (170)

Epigenetic Regulation in Acute Myeloid Leukemia: Molecular Mechanisms and Clinical Implications. [PDF]

Cancers (Basel)
Xu J, Lacaud G.
europepmc   +1 more source

Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments. [PDF]

Cancers (Basel)
Testa U, Pelosi E, Castelli G.
europepmc   +1 more source

Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL-Fusion Leukemia. [PDF]

Cancer Sci
Li A, Zhang Y, Li Z, Liu A, Zhang L, Gao S, Lin X, Liu X, Li H, Jin G, Xu B.   +10 more
europepmc   +1 more source

Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting. [PDF]

Exp Hematol Oncol
Yu H, Shi T, Zhu HH.
europepmc   +1 more source

Inhibiting menin attenuates high-fat diet-induced weight gain by limiting intestinal lipid absorption in mice. [PDF]

J Clin Invest
Cao X, Zhou P, Meng H, Guo Z, Cao Y, Wang C, Liu L, Guo Y, Wang Y, Xin G, Liu D, Geng F, Ma J.   +12 more
europepmc   +1 more source

Novel treatment strategies in acute myeloid leukemia. [PDF]

Blood Res
Simkhada S, Joshi U, Dhakal P.
europepmc   +1 more source

NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives. [PDF]

Int J Hematol
Shimosato Y, Goyama S.
europepmc   +1 more source

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care. [PDF]

Cancers (Basel)
Alati C, Molica M, Pitea M, Marafioti V, Porto G, Policastro G, Bilardi E, Utano G, Giordano L, Sgarlata A, Delfino IM, Idato A, Santoro G, Rossi M, Martino M.   +14 more
europepmc   +1 more source

The new era of AML therapy: current standards and emerging targets. [PDF]

Int J Clin Oncol
Hosono N.
europepmc   +1 more source

The Histone-Lysine N-Methyltransferase (KMT2) Family in Health and Disease. [PDF]

MedComm (2020)
Wang Q, Bo Z, Zhang Y, Chen Y, Wang Z, Tong S, Xu A, Zhang J, Liu Y.   +8 more
europepmc   +1 more source